The Cancer Drug Development Forum (CDDF) shared a post on LinkedIn:
“Save the Date: CDDF and EORTC Joint Workshop on Health Technology Assessment in Cancer Drug Development
In collaboration with EORTC – European Organisation for Research and Treatment of Cancer, the CDDF will host a multi-stakeholder workshop on Health Technology Assessment (HTA) in Cancer Drug Development.
Date: 5–6 October 2026
Location: Brussels, Belgium
Registration: will open soon
This workshop will bring together a multi-stakeholder group of experts to explore the complexities and opportunities of HTA in oncology. The program will feature four dedicated sessions, each addressing key aspects of this important topic:
- Setting the Scene: HTA Landscape and Societal Needs
- Implementation of HTA Regulation: Practical Learnings
- HTA Regulation and Methodological Foundations
- Looking Ahead: Preparing for Future Innovation
Stay tuned for more details in the coming weeks!”
EORTC – European Organisation for Research and Treatment of Cancer shared this post, adding:
“We’re pleased to collaborate with CDDF on this upcoming joint workshop on Health Technology Assessment (HTA) in cancer drug development, taking place in Brussels on 5–6 October 2026.
Bringing together a multi‑stakeholder community, this workshop will explore how HTA can better support patient access and innovation in oncology.”